Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

December 20, 2025

Study Completion Date

December 20, 2025

Conditions
Cancer
Interventions
BEHAVIORAL

Intervention

All participants in this group will receive the standard of care intervention provided by the RN. This includes:Education in the clinic setting,Printed information about the chemotherapy drug and chemotherapy side effects. The RN will be blinded to the arm of study to which each patient is allocated.

Trial Locations (1)

19141

RECRUITING

Albert Einstein Healthcare Network, Philadelphia

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Thomas Jefferson University

OTHER

NCT03245411 - Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients | Biotech Hunter | Biotech Hunter